vdac1 monoclonal primary antibody (Boster Bio)
Boster Bio is a verified supplier 
Boster Bio manufactures this product 
92
Structured Review
Boster Bio
vdac1 monoclonal primary antibody
Vdac1 Monoclonal Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vdac1+monoclonal+primary+antibody/Anti-VDAC1%2FPorin+Rabbit+Monoclonal+Antibody/pm39142491-102-24-28
Average 92 stars, based on 1 article reviews
Vdac1 Monoclonal Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vdac1+monoclonal+primary+antibody/Anti-VDAC1%2FPorin+Rabbit+Monoclonal+Antibody/pm39142491-102-24-28
Average 92 stars, based on 1 article reviews
vdac1 monoclonal primary antibody - by Bioz Stars,
2026-10
92/100 stars
Images
Related Articles
Blocking Assay:Article Title: Mfn2 R364W , Mfn2 G176S , and Mfn2 H165R mutations drive Charcot-Marie-Tooth type 2A disease by inducing apoptosis and mitochondrial oxidative phosphorylation damage. Article Snippet: Charcot-Marie-Tooth type 2A (CMT2A) is a single-gene motor sensory neuropathy caused by Mfn2 mutation.. It is generally believed that CMT2A involves mitochondrial fusion disruption.. However, how Mfn2 mutation mediates the mitochondrial membrane fusion loss and its further pathogenic mechanisms remain unclear. Article Title: Hydrolytic Cleavage of Optic Atrophy 1 Drives the Pathogenesis of CMT2A Neuropathy Caused by Mfn2 Mutation Article Snippet: 13 Background 14 Charcot-Marie-Tooth subtype 2A (CMT2A) is an autosomal dominant single-gene motor sensory 15 neuropathy that is caused by mitofusin 2 (Mfn2) mutation.. It is generally believed that CMT2A 16 involves mitochondrial fusion disruption.. However, how to ameliorate the loss of mitochondrial 17 membrane fusion in CMT2A remains unclear. Incubation:Article Title: Mfn2 R364W , Mfn2 G176S , and Mfn2 H165R mutations drive Charcot-Marie-Tooth type 2A disease by inducing apoptosis and mitochondrial oxidative phosphorylation damage. Article Snippet: Charcot-Marie-Tooth type 2A (CMT2A) is a single-gene motor sensory neuropathy caused by Mfn2 mutation.. It is generally believed that CMT2A involves mitochondrial fusion disruption.. However, how Mfn2 mutation mediates the mitochondrial membrane fusion loss and its further pathogenic mechanisms remain unclear. Article Title: Hydrolytic Cleavage of Optic Atrophy 1 Drives the Pathogenesis of CMT2A Neuropathy Caused by Mfn2 Mutation Article Snippet: 13 Background 14 Charcot-Marie-Tooth subtype 2A (CMT2A) is an autosomal dominant single-gene motor sensory 15 neuropathy that is caused by mitofusin 2 (Mfn2) mutation.. It is generally believed that CMT2A 16 involves mitochondrial fusion disruption.. However, how to ameliorate the loss of mitochondrial 17 membrane fusion in CMT2A remains unclear. |